Illegal Pharma Ads Down 4.46% In China Last Year: SAIC
This article was originally published in PharmAsia News
Sample monitoring conducted by China's State Administration for Industry & Commerce (SAIC) in 2012 showed that illegal advertisements, including these for pharmaceuticals, dropped 4.5%, vice minister Gan Li said.
You may also be interested in...
Mooted some time ago, the Medicare Part D Drug Rebate Rule and the Medicare Part B Most-Favored-Nation Model have now been finalized by US President Donald Trump. But US off-patent body the Association for Accessible Medicines feels “further action is necessary.”
Lannett will launch a further seven products in fiscal 2021, after launching four products recently in the first quarter of FY21. The company also plans to pay off its Term Loan ‘A’ in full, by the end of November 2020.
Pfizer has now received a formal European Commission approval for its Nyvepria biosimilar pegfilgrastim. The approval puts the firm in direct competition with several other versions of the Neulasta original.